"Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan

Daprodustat is an approved treatment for anemia of chronic kidney disease (CKD) in Japan. Click to show full abstract

Daprodustat is an approved treatment for anemia of chronic kidney disease (CKD) in Japan.

Keywords: kidney disease; daprodustat; chronic kidney; anemia chronic

Journal Title: Therapeutic Apheresis and Dialysis
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended